Notably, an additional obstacle in the delineation of the exact clinical relevance of sPD-1 and sPD-L1 in NSCLC is the existing ambiguity regarding the exact source of these secreted proteins in the peripheral circulation, particularly with regard to sPD-L1. Here, HOXD13 is linked to non-small cell lung carcinoma.